PRP Joint Therapy Solutions in Escondido, CA

How Escondido is not Florida First Coast

Joe Bradley will tell you the same thing he tells his own staff: epidemiology first, then MAC, then SKU. CDC PLACES (2023, crude) estimates 11.3% of adults in Escondido have diagnosed diabetes — 0.7 points below the U.S. 12% figure. 14.1% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Then we pick prp joint therapy against that mix.

Cash PRP and Medicare CTPs in the same hallway

• Adult arthritis here is 20.3% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. 14.1% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. PRP is autologous and not a 361 allograft, but “patient prefers regenerative” is still not medical necessity in California.
• JE (Noridian Healthcare Solutions) is the contractor that will review CTP units, application frequency, and wound measurements for California Part B claims. Practices that skip MAC education typically see denials before they see outcomes.
• California is outside CDC's historical Diabetes Belt core, but the national 12% diabetes figure still applies as a planning baseline until a clinic uses its own payer mix. Clinics asking for regenerative inventory still have to separate HCT/P 361 homologous-use products from unapproved “stem cell” claims (FDA 21 CFR 1271).

Uninsured mix and Medicare CTPs in the same building

JE reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Escondido is 11.3% or not. PLACES is planning data. The LCD is the claim.

How we’d stand this up in clinic